Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 27 ... "Adiponectin is an adipokine secreted by differentiated adipocytes. Clinical studies suggest a negative correlation between oxidative stress and adiponectin levels ... additional information, contact N. Santanam, Marshall University, Dept. of Pharmacology Physiol & Toxicology, Joan C Edwards School Medical, 1 John Marshall Dr., Huntington, WV ...
2009 NOV 23 ... According to recent research published in the International Journal of Clinical Pharmacology and Therapeutics, "The objective of this study was to assess the relative ...
2009 NOV 23 ... exhibits also antipsychotic-like efficacy in some animal tests, and may be useful in clinical practice as a psychosis-attenuating drug in schizophrenic patients. However, 1MeTIQ did ... this condition," wrote M. Pietraszek and colleagues, Polish Academy of Sciences, Pharmacology Department. The researchers concluded: "The present study suggests that ...
2009 NOV 24 ... and colleagues published their study in Methods and Findings in Experimental and Clinical Pharmacology (HISTOLOGICAL LOCALIZATION AND ANALYTICAL EVALUATION OF HEPARIN IN THE WEDGE CLAM DONAX ...
2009 NOV 23 ... Krauss and colleagues published their study in International Journal of Clinical Pharmacology and Therapeutics (Influence of L-arginine on the nitric oxide concentration and level of ...
2009 NOV 23 ... against typhoid fever based on an attenuated strain of S enterica serovar Typhi. Several clinical trials have been completed for the vaccine, including large phase II trials in the US ... Keywords: City:Delhi, Country:India, Biotechnology, Drug Resistance, Molecular Pharmacology, Molecular Therapies, Salmonella enterica, Therapy, Treatment, Typhoid Fever, Vaccines, ...
2009 NOV 23 ... Sahin and colleagues published their study in Methods and Findings in Experimental and Clinical Pharmacology (THE DUAL EFFECTS OF LEPTIN ON AORTIC RINGS WITH AND WITHOUT ENDOTHELIUM ISOLATED FROM ...
2009 NOV 23 ... of the protective effect of DNA vaccination in animal models has provided support for clinical trials. VCL-CB01, under development byVical Inc for the prevention of hCMV infection and ... Trial Research, DNA Research, DNA Vaccines, Immunization, Medical Device, Molecular Pharmacology, Molecular Therapies, Public Health, Therapy, Treatment, Vaccination, University of ...
2009 NOV 23 ... have shown promise as a tool for gene delivery-based therapeutic applications. Their clinical use is however limited by therapeutically suboptimal transduction levels in cell types ... State:PA, Country:United States, Life Sciences, Pediatrics, Virology, Molecular Pharmacology, Molecular Therapies, Therapy, Treatment, Biotechnology, Gene Therapy, Genetics, ...
2009 NOV 23 ... 10.2215/CJN.03980609." Barreto and colleagues published their study in Clinical Journal of the American Society of Nephrology (Serum Indoxyl Sulfate Is Associated with ... additional information, contact Z.A. Massy, Amiens University Hospital, Division Clinic Pharmacology, INSERM, ERI 12, EA 4292, Avenue Rene Laennec, F-80054 Amiens, France. ...
2009 NOV 23 ... research from Liverpool, the United Kingdom, "Genotypic algorithms used to predict the clinical efficacy of lopinavir/ritonavir (LPV/r) have included a range of mutation lists and ... For additional information, contact A. Hill, University of Liverpool, Pharmacology Research Laboratories, Liverpool, UK. Publisher contact information for the ...
2009 NOV 23 ... an update of all therapeutic applications of synthetic HDL tested in animal models or in clinical trials," wrote C. Parolini and colleagues, University of Milan. The ... models." Parolini and colleagues published their study in Current Vascular Pharmacology (HDL Therapy for the Treatment of Cardiovascular Diseases. Current Vascular ...
2009 NOV 23 ... "of review This review briefly discusses the definition and clinical presentation of neuropathic pain and highlights recent advances in the treatment of ... Jensen and colleagues published their study in Current Opinion in Neurology (Pharmacology and treatment of neuropathic pains. Current Opinion in Neurology, 2009;22(5):467-474). ...
2009 NOV 23 ... EAE but not in healthy rats. The overall binding efficacy paralleled the severity of the clinical score, but targeting was observed already before clinical manifestation of inflammation. ... Autoimmune Encephalomyelitis, Immunology, Inflammation, Liposomes, Microscopy, Molecular Pharmacology, Molecular Therapies, Multiple Sclerosis, Neuroimmunology, Neuroinflammation, Neurology, ...
2009 NOV 23 ... For more information, contact I. Paris, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, ICBM, Independencia1027, Casilla Santiago-7, 70000, Chile. ...
2009 NOV 23 ... to recent research published in the journal Methods and Findings in Experimental and Clinical Pharmacology, "A prospective, randomized, double-blind, placebo-controlled study was undertaken to ...
2009 NOV 23 ... tumor model in mice. To further establish the candidature of this nanomedicine for clinical trials, in this communication we have tested the preclinical efficacy of squalenoyl ... Trial Research, Clinical Trials, Enzymes, Gemcitabine, Immunosuppressant, Molecular Pharmacology, Molecular Therapies, Nucleoside Analog, Oncology, Pharmaceuticals, Pre-Trials Research, ...
2009 NOV 23 ... a vulnerability to ethanol during two hours in vitro should be required to demonstrate clinical safety by going through in vivo testing with an alcoholic beverage of up to 40% ethanol ... Drugs, Gastroenterology, Hydromorphone Hydrochloride, Mental Health, Molecular Pharmacology, Molecular Therapies, Pharmaceuticals, Pharmacokinetics, Therapy, Treatment, Uppsala ...
